よむ、つかう、まなぶ。
07【参考資料２】肺炎球菌コンジュゲートワクチン（小児用）作業チーム報告書 (8 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_40343.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第25回 5／23）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
追加参考文献
1. 神谷齊ほか. 小児用 7 価肺炎球菌結合型ワクチンの医療経済効果. 小児科臨
床 61: 2233-2241, 2008.
2. Lieu TA, et al. Projected cost-effectiveness of pneumococcal conjugate
vaccination of healthy infants and young children. JAMA 283:1460-1468
2000.
3. Ray GT, et al. Cost-effectiveness of pneumococcal conjugate vaccine:
evidence from the first 5 years of use in the United States incorporating
herd effects. Pediatr Infect Dis J 25:494-501 2006
4. McIntosh ED, et al. The cost-burden of paediatric pneumococcal disease in
the UK and the potential cost-effectiveness of prevention using 7-valent
pneumococcal conjugate vaccine.Vaccine 21:2564-2572 2003.
5. McIntosh ED, et al. Pneumococcal pneumonia in the UK--how herd
immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate
vaccine (PCV). Vaccine 23:1739-1745 2005.
6. Melegaro A, et al. Cost-effectiveness analysis of pneumococcal conjugate
vaccination in England and Wales. Vaccine 22:4203-4214 2004.
7. Asensi F, et al. A pharmacoeconomic evaluation of seven-valent
pneumococcal conjugate vaccine in Spain. Value Health 7:36-51 2004.
8. Navas E, et al. Cost-benefit and cost-effectiveness of the incorporation of
the pneumococcal 7-valent conjugated vaccine in the routine vaccination
schedule of Catalonia (Spain).Vaccine 23:2342-2348 2005.
9. Wisløff T, et al. Cost effectiveness of adding 7-valent pneumococcal
conjugate (PCV-7) vaccine to the Norwegian childhood vaccination
program.Vaccine 24:5690-5699 2006.
10. Bos JM, et al. Epidemiologic impact and cost-effectiveness of universal
infant vaccination with a 7-valent conjugated pneumococcal vaccine in the
Netherlands. Clin Ther 25:2614-2630 2003.
11. Marchetti M, et al. Cost-effectiveness of universal pneumococcal
vaccination for infants in Italy. Vaccine 23:4565-4576 2005.
12. Salo H, et al. Economic evaluation of pneumococcal conjugate vaccination
in Finland. Scand J Infect Dis 37:821-832 2005.
13. Claes C, et al. Cost effectiveness of pneumococcal vaccination for infants
and children with the conjugate vaccine PnC-7 in Germany.
Pharmacoeconomics 21:587-600 2003.
14. Ess SM, et al. Cost-effectiveness of a pneumococcal conjugate
7
1. 神谷齊ほか. 小児用 7 価肺炎球菌結合型ワクチンの医療経済効果. 小児科臨
床 61: 2233-2241, 2008.
2. Lieu TA, et al. Projected cost-effectiveness of pneumococcal conjugate
vaccination of healthy infants and young children. JAMA 283:1460-1468
2000.
3. Ray GT, et al. Cost-effectiveness of pneumococcal conjugate vaccine:
evidence from the first 5 years of use in the United States incorporating
herd effects. Pediatr Infect Dis J 25:494-501 2006
4. McIntosh ED, et al. The cost-burden of paediatric pneumococcal disease in
the UK and the potential cost-effectiveness of prevention using 7-valent
pneumococcal conjugate vaccine.Vaccine 21:2564-2572 2003.
5. McIntosh ED, et al. Pneumococcal pneumonia in the UK--how herd
immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate
vaccine (PCV). Vaccine 23:1739-1745 2005.
6. Melegaro A, et al. Cost-effectiveness analysis of pneumococcal conjugate
vaccination in England and Wales. Vaccine 22:4203-4214 2004.
7. Asensi F, et al. A pharmacoeconomic evaluation of seven-valent
pneumococcal conjugate vaccine in Spain. Value Health 7:36-51 2004.
8. Navas E, et al. Cost-benefit and cost-effectiveness of the incorporation of
the pneumococcal 7-valent conjugated vaccine in the routine vaccination
schedule of Catalonia (Spain).Vaccine 23:2342-2348 2005.
9. Wisløff T, et al. Cost effectiveness of adding 7-valent pneumococcal
conjugate (PCV-7) vaccine to the Norwegian childhood vaccination
program.Vaccine 24:5690-5699 2006.
10. Bos JM, et al. Epidemiologic impact and cost-effectiveness of universal
infant vaccination with a 7-valent conjugated pneumococcal vaccine in the
Netherlands. Clin Ther 25:2614-2630 2003.
11. Marchetti M, et al. Cost-effectiveness of universal pneumococcal
vaccination for infants in Italy. Vaccine 23:4565-4576 2005.
12. Salo H, et al. Economic evaluation of pneumococcal conjugate vaccination
in Finland. Scand J Infect Dis 37:821-832 2005.
13. Claes C, et al. Cost effectiveness of pneumococcal vaccination for infants
and children with the conjugate vaccine PnC-7 in Germany.
Pharmacoeconomics 21:587-600 2003.
14. Ess SM, et al. Cost-effectiveness of a pneumococcal conjugate
7